Obsessive-compulsive symptoms and brain lesions compatible with multiple sclerosis.
Autoimmune
CSF
Inflammation
Multiple sclerosis
OCD
RIS
Journal
Journal of neural transmission (Vienna, Austria : 1996)
ISSN: 1435-1463
Titre abrégé: J Neural Transm (Vienna)
Pays: Austria
ID NLM: 9702341
Informations de publication
Date de publication:
30 Jan 2024
30 Jan 2024
Historique:
received:
30
08
2023
accepted:
27
12
2023
medline:
30
1
2024
pubmed:
30
1
2024
entrez:
30
1
2024
Statut:
aheadofprint
Résumé
Autoimmune-mediated obsessive-compulsive disorder (OCD) can occur in multiple sclerosis (MS). Here, a well-studied case study of a patient with OCD and MS-compatible diagnostic findings is presented. The 42-year-old female patient had displayed OCD symptoms for 6 years. Magnetic resonance imaging (MRI) identified several periventricular and one brainstem lesion suggestive of demyelination. Cerebrospinal fluid (CSF) analyses detected an increased white blood cell count, intrathecal immunoglobulin (Ig) G and IgM synthesis, CSF-specific oligoclonal bands, and a positive MRZ reaction. Neopterin was increased, but sarcoidosis was excluded. In the absence of neurological attacks and clues for MRI-based dissemination in time, a radiologically isolated syndrome, the pre-disease stage of MS, was diagnosed. Neurotransmitter measurements of CSF detected reduced serotonin levels. In the absence of visible strategic demyelinating lesions within the cortico-striato-thalamo-cortical circuits, OCD symptoms may relate to reduced intrathecal serotonin levels and mild neuroinflammatory processes. Serotonin abnormalities in MS should be studied further, as they could potentially explain the association between neuroinflammation and mental illnesses.
Identifiants
pubmed: 38289491
doi: 10.1007/s00702-023-02737-z
pii: 10.1007/s00702-023-02737-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Bechter K (2020) The challenge of assessing mild neuroinflammation in severe mental disorders. Front Psychiatry 11:773
doi: 10.3389/fpsyt.2020.00773
pubmed: 32973573
pmcid: 7469926
Ellwardt E, Muthuraman M, Gonzalez-Escamilla G, Chirumamilla VC, Luessi F, Bittner S, Zipp F, S Groppa, Fleischer V (2022) Network alterations underlying anxiety symptoms in early multiple sclerosis. J Neuroinflammation 19:119
Endres D, von Zedtwitz K, Matteit I, Bünger I, Foverskov-Rasmussen H, Runge K, Feige B, Schlump A, Maier S, Nickel K, Berger B, Schiele MA, Cunningham JL, Domschke K, Prüss H, Tebartz van Elst L (2022) Spectrum of novel anti-central nervous system autoantibodies in the cerebrospinal fluid of 119 patients with schizophreniform and affective disorders. Biol Psychiatry 92:261–274
Endres D, Hannibal L, Zaltenbach B, Schiele MA, Runge K, Nickel K, Berger B, Domschke K, Venhoff N, Prüss H, Tebartz van Elst L (2022) Case Report: Possible autoimmune obsessive-compulsive disorder with postpartum onset. Front Immunol 13:970448
Endres D, von Zedtwitz K, Urbach H, Dersch R, Runge K, Feige B, Nickel K, Schiele MA, Prüss H, Domschke K, Reisert M, Coenen VA (2022) Obsessive-compulsive symptoms in two patients with strategic basal ganglia lesions. Mol Psychiatry 28(2):528–531
Endres D, Pollak TA, Bechter K, Denzel D, Pitsch K, Nickel K, Runge K, Pankratz B, Klatzmann D, Tamouza R, Mallet L, Leboyer M, Prüss H, Voderholzer U, Cunningham JL, ECNP Network Immuno-NeuroPsychiatry, Domschke K, Tebartz van Elst L, Schiele MA (2022) Immunological causes of obsessive-compulsive disorder: is it time for the concept of an “autoimmune OCD” subtype? Transl Psychiatry 12:5
Endres D, Mertens L, Berger B, Reisert M, Runge K, Nickel K, Domschke K, Schiele MA, Urbach H, Venhoff N, Prüss H, Tebartz van Elst L (2022) Autoimmune obsessive-compulsive disorder with novel anti-basal ganglia antibodies. Psychother Psychosom 91:214–216
Endres D, Pankratz B, Robinson T, Pitsch K, Göbel T, Runge K, Schlump A, Nickel K, Reisert M, Urbach H, Voderholzer U, Venhoff N, Domschke K, Prüss H, Schiele MA, Tebartz van Elst L (2022) Autoimmune obsessive-compulsive disorder with novel anti-CNS autoantibodies in cerebrospinal fluid. Mol Psychiatry 27:3926–3928
Foroughipour M, Behdani F, Hebrani P, Marvast MN, Esmatinia F, Akhavanrezayat A (2012) Frequency of obsessive-compulsive disorder in patients with multiple sclerosis: a cross-sectional study. J Res Med Sci 6
Khatri IA, Aljwair S, Alammar H, Altariq A, Masud N, Al Malik Y, Kojan S (2021) Social anxiety and obsessive-compulsive disorder are common among persons with multiple sclerosis at king abdulaziz medical city. Riyadh Cureus 13(2):e13619
pubmed: 33816018
Korostil M, Feinstein A (2007) Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler J 13:67–72
doi: 10.1177/1352458506071161
Mandal R, Guo AC, Chaudhary KK, Liu P, Yallou FS, Dong E, Aziat F, Wishart DS (2012) Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update. Genome Med 4:38
doi: 10.1186/gm337
pubmed: 22546835
pmcid: 3446266
Murr C, Widner B, Wirleitner B, Fuchs D (2002) Neopterin as a marker for immune system activation. Curr Drug Metab 3:175–187
doi: 10.2174/1389200024605082
pubmed: 12003349
Robbins TW, Vaghi MM, Banca P (2019) Obsessive-compulsive disorder: puzzles and prospects. Neuron 102:27–47
doi: 10.1016/j.neuron.2019.01.046
pubmed: 30946823
Runge K, Reisert M, Feige B, Nickel K, Urbach H, Venhoff N, Tzschach A, Schiele MA, Hannibal L, Prüss H, Domschke K, Tebartz van Elst L, Endres D (2023) Deep clinical phenotyping of patients with obsessive-compulsive disorder: an approach towards detection of organic causes and first results. Transl Psychiatry 13:83
San Hernandez AM, Singh C, Valero DJ, Nisar J, Trujillo Ramirez JI, Kothari KK, Isola S, Gordon DK (2020) Multiple sclerosis and serotonin: potential therapeutic applications. Cureus 12(11):e11293
pubmed: 33274166
pmcid: 7707915
Sepehrinezhad A, Shahbazi A, Bozorgmehr A, Kateb B, Yamamoto V, Negah SS (2022) STAT3 and NTRK2 genes predicted by the bioinformatics approach may play important roles in the pathogenesis of multiple sclerosis and obsessive-compulsive disorder. J Pers Med 12:1043
doi: 10.3390/jpm12071043
pubmed: 35887540
pmcid: 9325211
Shephard E, Stern ER, van den Heuvel OA, Costa DLC, Batistuzzo MC, Godoy PBG, Lopes AC, Brunoni AR, Hoexter MQ, Shavitt RG, Reddy YCJ, Lochner C, Stein DJ, Simpson HB, Miguel EC (2021) Toward a neurocircuit-based taxonomy to guide treatment of obsessive–compulsive disorder. Mol Psychiatry 26:4583–4604
doi: 10.1038/s41380-020-01007-8
pubmed: 33414496
pmcid: 8260628
Stein DJ, Costa DLC, Lochner C, Miguel EC, Reddy YCJ, Shavitt RG, van den Heuvel OA, Simpson HB (2019) Obsessive-compulsive disorder. Nat Rev Dis Primer 5:52
doi: 10.1038/s41572-019-0102-3
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162–173
doi: 10.1016/S1474-4422(17)30470-2
pubmed: 29275977
Tinelli E, Francia A, Quartuccio EM, Morreale M, Contessa GM, Pascucci S, Sbardella E, Pozzilli C, Pantano P (2013) Structural brain MR imaging changes associated with obsessive-compulsive disorder in patients with multiple sclerosis. Am J Neuroradiol 34:305–309
doi: 10.3174/ajnr.A3210
pubmed: 22821917
pmcid: 7965097
Uguz F, Akpinar Z, Ozkan I, Tokgoz S (2008) Mood and anxiety disorders in patients with multiple sclerosis. Int J Psychiatry Clin Pract 12:19–24
doi: 10.1080/13651500701330825
pubmed: 24916492
Voderholzer U, Favreau M, Rubart A, Staniloiu A, Wahl-Kordon A, Zurowski B, Kathmann N (2022) Treatment of obsessive-compulsive disorders: recommendations of the revised S3 guidelines on obsessive-compulsive disorders. Nervenarzt 93:678–687
doi: 10.1007/s00115-022-01336-9
pubmed: 35763051